News

Read up on the latest news and recent information regarding cannabinoid-based medicine.

Cannabis Lab Testing Problems Continue Nationwide

Cannabis Lab Testing Problems Continue Nationwide

In Maine, a laboratory released a study they conducted, finding a 17% failure rate of dangerous pesticides in cannabis samples tested. The state requires testing for adult use cannabis, but not for medical cannabis. Just under 4% of adult use samples failed a...

Lone Star Cannabis: What’s Holding Texas Back?

Lone Star Cannabis: What’s Holding Texas Back?

Adult-use cannabis has gained steam across the nation as more and more states jump on the legalization train. As of the writing of this article, 23 states have legalized adult-use while another 15 have allowed the sale of cannabis for medicinal purposes, for a total...

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

HHS Recommends Rescheduling Cannabis, Surprising an Entire Industry

In the most unexpected development to hit the cannabis industry in years, the U.S. Department of Health and Human Services’ (HHS) Secretary Xavier Becerra shared his agency’s recommendation that, based on data and scientific analysis, cannabis, a Schedule I drug under...

The CBD Regulatory Environment in Europe: Part 4

The CBD Regulatory Environment in Europe: Part 4

This is the final piece of a four-part series discussing European cannabis regulations. Click here for Part One, here for Part Two and here for Part Three. Part Four wraps up the series below.  Where is the future of CBD heading? A review of these various...

Alternatives to Bankruptcy for Cannabis Companies: Part 3

Alternatives to Bankruptcy for Cannabis Companies: Part 3

Part 1 of this series discussed the lack of bankruptcy protections for cannabis companies, since bankruptcy in the U.S. is an exclusively federal procedure and cannabis remains illegal under federal law and proposed a number of alternative options for businesses...

The CBD Regulatory Environment in Europe: Part 3

The CBD Regulatory Environment in Europe: Part 3

This is Part Three of a four-part series discussing European cannabis regulations. Click here for Part One and here for Part Two. Part Three dives into dosage, approvals and more. Stay tuned for the final Part Four, coming next week. But does CBD harm the liver? Here,...

Congress Wants YOU To Make Safe Products.

Congress Wants YOU To Make Safe Products.

Recently, Congress requested detailed information regarding the regulation of CBD and other cannabinoids. This comes on the heels of frustration around federal inaction with regards to cannabinoid-containing products produced from Cannabis sativa L. plant extracts...

HHS Recommends DEA Reschedule Cannabis to Schedule III

HHS Recommends DEA Reschedule Cannabis to Schedule III

Massively promising news for the cannabis industry today that many are calling historic: the Department of Health and Human Services (HHS) has sent a letter to the Drug Enforcement Administration (DEA), recommending that cannabis be rescheduled from Schedule I to...

Payment Processing & CBD Products: What to Know

Payment Processing & CBD Products: What to Know

In the wake of the 2018 Farm Bill, the horizons of hemp-derived cannabis products expanded, offering nearly limitless opportunities for businesses and brands in the CBD industry to expand what they could offer to their customers. However, threading the path to...

The CBD Regulatory Environment in Europe: Part 2

The CBD Regulatory Environment in Europe: Part 2

This is Part Two of a four-part series discussing European cannabis regulations. Click here for Part One. Part Two analyzes the differences between the UK, the EU and the US. Part Three, coming next week, dives into dosage, approvals and more. Stay tuned for more. EU...

As Mastercard Exits Cannabis, There’s a Cash Opportunity

As Mastercard Exits Cannabis, There’s a Cash Opportunity

Late last month, Mastercard decided to halt their debit card transactions with cannabis dispensaries, notifying financial institutions and payment processors to stop processing purchases. This isn’t the first digital payment solution to swiftly exit the industry...

The CBD Regulatory Environment in Europe: Part 1

The CBD Regulatory Environment in Europe: Part 1

This is Part One of a four-part series discussing European cannabis regulations. Part One serves as an introduction. Part Two, coming next week, will analyze the differences between the UK, the EU and the US. Stay tuned for more. As I walk through any European...

Alternatives to Bankruptcy for Cannabis Companies: Part 1

Alternatives to Bankruptcy for Cannabis Companies: Part 1

The problems facing the cannabis industry arising from its ongoing status as a federally illegal enterprise are numerous and well documented: 280E tax burdens, limited access to banking, exclusion from capital markets, uneven access to federal intellectual property...

Safety & Compliance in the Absence of Regulatory Clarity & Consistency

Safety & Compliance in the Absence of Regulatory Clarity & Consistency

As the legal landscape surrounding cannabis continues to evolve, the creation of robust, sensible and consistent safety regulations remains stalled. A patchwork of broadly inconsistent state rules and regulations, along with years of federal inaction and policy...

2023 Cannabis Supply Chain Virtual Conference

2023 Cannabis Supply Chain Virtual Conference Click here to watch the recording Agenda Cannabis Packaging Solutions: Navigating Regulations, Quality & Environmental Impact Jack Grover, Founder & CEO, Grove Bags In the cannabis industry, packaging regulations...

Five Ingredients for a Successful Cannabis License Application

Five Ingredients for a Successful Cannabis License Application

In the rapidly evolving cannabis industry, in both new and emerging markets, securing a cannabis license is an essential step to establishing a successful business. However, navigating the application process can be complex, challenging and highly competitive. To help...